id,drug1,object,drug2,precipitant,certainty,contraindication,dateAdded,ddiPkEffect,ddiPkMechanism,effectConcept,homepage,label,numericVal,objectUri,pathway,precaution,precipUri,severity,uri,whoAnnotated,source,ddiType,evidence,evidenceSource,evidenceStatement,researchStatementLabel,researchStatement,managementOptions
623,http://bio2rdf.org/drugbank:DB00641,simvastatin,http://bio2rdf.org/drugbank:DB01118,amiodarone,None,None,None,None,None,None,None,"amiodarone is predicted to reduce the clearance of simvastatin by inhibition of CYP3A4",None,None,http://purl.obolibrary.org/obo/PR_000006130,None,None,None,http://dbmi-icode-01.dbmi.pitt.edu/dikb/resource/DDIPredictions/414,None,DIKB,DDIPrediction,None,None,None,None,None,None
5983,http://bio2rdf.org/drugbank:DB00641,Simvastatin,http://bio2rdf.org/drugbank:DB01118,Amiodarone,None,None,None,None,None,None,None,"Increased risk of rhabdomyolysis|",None,None,None,None,None,None,None,None,Drugbank,None,None,None,None,None,None,None
43774,http://bio2rdf.org/drugbank:DB00641,Simvastatin,http://bio2rdf.org/drugbank:DB01118,Amiodarone,None,None,None,None,None,None,None,None,None,None,None,True,None,None,http://rest.kegg.jp/ddi/D00434,None,Kegg,None,None,None,None,None,None,None
78798,http://bio2rdf.org/drugbank:DB00641,SIMVASTATIN,http://bio2rdf.org/drugbank:DB01118,AMIODARONE,None,None,None,None,"Inhibition of metabolism of simvastatin/ lovastatin by CYP3A4","Increased simvastatin/ lovastatin concentrations and risk of myopathy/ rhabdomyolysis",None,None,None,None,None,None,None,None,None,None,CredibleMeds,None,None,None,None,None,None,"Usually Avoid ·Consider Alternatives: Preferable statin alternatives include fluvastatin, rosuvastatin, or pravastatin. Predisposing risk factors for rhabdomyolysis include advanced age (>65 years), uncontrolled hypothyroidism, and renal impairment. ·Monitor: If alternative statins are not appropriate, monitor the patient for evidence of myopathy (muscle pain or weakness) and myoglobinuria (dark urine). The simvastatin dose should not exceed 20 mg/day in combination with amiodarone."
81642,http://bio2rdf.org/drugbank:DB00641,SIMVASTATIN,http://bio2rdf.org/drugbank:DB01118,AMIODARONE,None,None,None,None,None,None,None,None,None,None,None,None,None,None,None,None,NLM-Corpus,true,None,None,Caution_Interaction,None,None,None
82210,http://bio2rdf.org/drugbank:DB00641,Simvastatin,http://bio2rdf.org/drugbank:DB01118,Amiodarone,None,None,None,None,None,None,None,None,None,None,None,None,None,None,None,None,ONC-HighPriority,None,None,None,None,None,None,None
